Drug Development Technology Company Profile

08:22 EDT 21st June 2018 | BioPortfolio

Established in 1972, SPG Media PLC is an international business-to-business media company providing world-class controlled circulation magazines, internet reference portals, business conferences and forums.
Our extensive expertise, built through a long history in publishing, has led to an impressive array of products. Our well-respected websites have established themselves as leading sources of information within the industries they serve while our print publications feature editorial content designed to present and analyse cutting edge technology and strategies.
Our mission is to provide senior executives, decision-makers and business communities throughout the world with valued information and services, by communicating industry developments, offering informed opinion and promoting our customers' products and servises


Brunel House55-57 North Wharf Road
W2 1LA
United Kingdom


Phone: 44 207 915 9957
Fax: 44 207 915 9958

News Articles [3124 Associated News Articles listed on BioPortfolio]

Major $115M Fundraising Fuels AI Drug Development

BenevolentAI has raised its second round of fundraising to expand the drug developing capabilities of its artificial intelligence technology. The technology could significantly increase the speed and ...

Migraine drug could prove effective against nerve agents

Drug development company Proniras has entered a contract with the US Biomedical Advanced Research and Development Authority (BARDA) to explore...Read More... The post Migraine drug could prove effecti...

Otsuka to advance clinical development of anti-TB drug

Japan-based healthcare firm Otsuka Pharmaceutical has secured funding from the Bill & Melinda Gates Foundation to accelerate clinical development of...Read More... The post Otsuka to advance clini...

New Australian grant to support rare cancer drug development

Australia Health Minister Greg Hunt has announced new funding to support various organisations in the clinical development of new drugs...Read More... The post New Australian grant to support rare can...

Revived Leukemia drug follows a historical development path in three stages

Over the course of 2017, the acute myeloid leukemia (AML) market has experienced dramatic changes with the approval of various...Read More... The post Revived Leukemia drug follows a historical develo...

Fujitsu announces development of molecular simulation technology for drug discovery

Fujitsu Laboratories Ltd. and Fujitsu Limited today announced the development of molecular simulation technology for drug discovery that can accurately estimate binding affinity, which represents the ...

Cancer Research Technology: Driving Cancer Drug Development

In this programme Fintan Walton talks to Dr Keith Blundy, CEO of Cancer Research Technology, the drug development and commercialisation arm of Cancer Research UK. Having described the relationship bet...

BenevolentAI raises $115m to fund drug development

Its technology could cut the early stage drug discovery process by four years, says the company

PubMed Articles [4712 Associated PubMed Articles listed on BioPortfolio]

Integration of Antibody Array Technology into Drug Discovery and Development.

Antibody arrays represent a high-throughput technique that enables the parallel detection of multiple proteins with minimal sample volume requirements. In recent years, antibody arrays have been widel...


In the last few years there has been a huge progress in a development of printing techniques and their application in pharmaceutical sciences and particularly in the pharmaceutical technology. The var...

Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles-A Platform for Drug Development.

Mesoporous silica nanoparticles (MSNs) have shown great potential in improving drug delivery of poorly water soluble (BCS class II, IV) and poorly permeable (BCS class III, IV) drugs, as well as facil...

Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness.

The advances in drug delivery technologies have enabled pharmaceutical scientists to deliver a drug through various administration routes and optimize the drug release and absorption. The wide range o...

Delivering precision antimicrobial therapy through closed-loop control systems.

Sub-optimal exposure to antimicrobial therapy is associated with poor patient outcomes and the development of antimicrobial resistance. Mechanisms for optimizing the concentration of a drug within the...

Clinical Trials [5131 Associated Clinical Trials listed on BioPortfolio]

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

Improving Outcomes Using Technology for Children Who Are DHH

This study evaluates the efficacy of using augmentative and alternative communication (AAC) technology for enhancing language development in children who are deaf or hard of hearing. Half ...

Imaging the Neurochemistry of Drug Addiction With PET

Our project has two overarching goals. 1) We will use newly developed positron emission tomography (PET) technology to investigate the dopaminergic neurochemistry of drugs of abuse includi...

Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis

Background: Drug resistant tuberculosis is a serious public health problem that threatens the health of human life and the development of society and economy. At present, the diagnosis of...

Development of a Screening Strategy for Community-Based Adverse Drug Related Events in the Emergency Department

Adverse Drug Related Events (ADREs) are a leading cause of Emergency Department (ED) visits in Canada. However emergency physicians recognize only half of all ADREs in patients presenting ...

Companies [4429 Associated Companies listed on BioPortfolio]

Receptron Incorporated

Receptron has a novel and proprietary position in drug discovery and development. The company's original focus was on diabetes but now has expanded to include a diverse portfolio of research and devel...

Locum International

The Locum International Group is a limited Research Association comprising of :(a.) A Pharmaceutical Research and Development Company with extensive experience in product development, manufacturing, r...

TransPharma Medical Ltd

stablished in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug del...

Anchor Therapeutics, Inc.

Anchor Therapeutics, Inc. is a leader in the development of pepducin technology. The Company is engaged in the licensing of pepducin technology as research tools for drug developm...

Penwest Pharmaceuticals

Penwest Pharmaceuticals is engaged in the research, development and commercialization of novel drug delivery technologies. Based on its extensive expertise in developing and manufacturing tabletting i...

More Information about "Drug Development Technology" on BioPortfolio

We have published hundreds of Drug Development Technology news stories on BioPortfolio along with dozens of Drug Development Technology Clinical Trials and PubMed Articles about Drug Development Technology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Drug Development Technology Companies in our database. You can also find out about relevant Drug Development Technology Drugs and Medications on this site too.

Quick Search


Relevant Topic

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Corporate Database Quicklinks

Searches Linking to this Company Record